These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28429228)

  • 1. Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent.
    Semkina AS; Abakumov MA; Grinenko NF; Lipengolts AA; Nukolova NV; Chekhonin VP
    Bull Exp Biol Med; 2017 Apr; 162(6):808-811. PubMed ID: 28429228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the Size of Magnetic Nanoparticles and Efficiency of MRT Imaging of Cerebral Glioma in Rats.
    Semkina AS; Abakumov MA; Abakumov AM; Nukolova NV; Chekhonin VP
    Bull Exp Biol Med; 2016 Jun; 161(2):292-5. PubMed ID: 27383161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.
    Abakumov MA; Nukolova NV; Sokolsky-Papkov M; Shein SA; Sandalova TO; Vishwasrao HM; Grinenko NF; Gubsky IL; Abakumov AM; Kabanov AV; Chekhonin VP
    Nanomedicine; 2015 May; 11(4):825-33. PubMed ID: 25652902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
    Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
    Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors.
    Richard S; Boucher M; Lalatonne Y; Mériaux S; Motte L
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1515-1520. PubMed ID: 28017683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and bioreactivity of charged chitosan-coated superparamagnetic nanoparticles as promising contrast agents for magnetic resonance imaging.
    Kania G; Sternak M; Jasztal A; Chlopicki S; Błażejczyk A; Nasulewicz-Goldeman A; Wietrzyk J; Jasiński K; Skórka T; Zapotoczny S; Nowakowska M
    Nanomedicine; 2018 Jan; 14(1):131-140. PubMed ID: 28939490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
    Shan X; Yuan D; Xiong F; Gu N; Wang P
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD-functionalized ultrasmall iron oxide nanoparticles for targeted T₁-weighted MR imaging of gliomas.
    Luo Y; Yang J; Yan Y; Li J; Shen M; Zhang G; Mignani S; Shi X
    Nanoscale; 2015 Sep; 7(34):14538-46. PubMed ID: 26260703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal doxorubicin loaded magnetic nanoparticles for VEGF targeted theranostics of breast cancer.
    Semkina AS; Abakumov MA; Skorikov AS; Abakumova TO; Melnikov PA; Grinenko NF; Cherepanov SA; Vishnevskiy DA; Naumenko VA; Ionova KP; Majouga AG; Chekhonin VP
    Nanomedicine; 2018 Jul; 14(5):1733-1742. PubMed ID: 29730399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
    Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
    Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies.
    Danhier P; Deumer G; Joudiou N; Bouzin C; Levêque P; Haufroid V; Jordan BF; Feron O; Sonveaux P; Gallez B
    Oncotarget; 2017 Jun; 8(24):38876-38885. PubMed ID: 28467814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
    Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
    Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies.
    Feng ST; Li H; Luo Y; Cai H; Dong Z; Fang Z; Shuai X; Li ZP
    Curr Cancer Drug Targets; 2016; 16(6):551-60. PubMed ID: 27262319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters as Contrast Agents for Magnetic Resonance Imaging of Liver Tumor.
    Wei Y; Liao R; Liu H; Li H; Xu H; Zhou Q
    J Biomed Nanotechnol; 2015 May; 11(5):854-64. PubMed ID: 26349397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Surface Chemistry in Mediating the Uptake of Ultrasmall Iron Oxide Nanoparticles by Cancer Cells.
    Narkhede AA; Sherwood JA; Antone A; Coogan KR; Bolding MS; Deb S; Bao Y; Rao SS
    ACS Appl Mater Interfaces; 2019 May; 11(19):17157-17166. PubMed ID: 31017392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Dobrodumov AV; Zhakhov AV; Mikhrina AL; Pitkin E; Parr MA; Rolich VI; Simbircev AS; Ischenko AM
    Neoplasia; 2015 Jan; 17(1):32-42. PubMed ID: 25622897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells].
    Zhang GX; Li YJ; Zhang F; Zhao JL; Li KA; Hu YS
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):228-32. PubMed ID: 17425864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
    Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
    Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.